Published in Aliment Pharmacol Ther on December 07, 2009
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther (2014) 2.88
Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol (2011) 2.23
Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther (2011) 1.97
Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol (2010) 1.58
Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis. Aliment Pharmacol Ther (2014) 1.41
Microbiota-liver axis in hepatic disease. Hepatology (2013) 1.27
PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther (2011) 1.22
Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World J Hepatol (2015) 0.99
Cirrhosis and its complications: evidence based treatment. World J Gastroenterol (2014) 0.93
Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China. World J Gastroenterol (2013) 0.92
Gut microbiota-related complications in cirrhosis. World J Gastroenterol (2014) 0.90
All-cause mortality and liver-related outcomes following successful antiviral treatment for chronic hepatitis C. Dig Dis Sci (2014) 0.86
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota. World J Gastroenterol (2012) 0.85
The role of microbiota in hepatic encephalopathy. Gut Microbes (2014) 0.85
The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis. Dtsch Arztebl Int (2013) 0.85
Antibiotics for the treatment of hepatic encephalopathy. Metab Brain Dis (2013) 0.85
Hepatic encephalopathy associated with cancer or anticancer therapy. Gastrointest Cancer Res (2013) 0.83
Modified-orientation log to assess hepatic encephalopathy. Aliment Pharmacol Ther (2012) 0.82
Useful tests for hepatic encephalopathy in clinical practice. Curr Gastroenterol Rep (2014) 0.82
How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist. Eur J Gastroenterol Hepatol (2016) 0.82
Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy. World J Gastroenterol (2014) 0.80
Meta-analysis: The diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy. Aliment Pharmacol Ther (2013) 0.80
Covert and Overt Hepatic Encephalopathy: Diagnosis and Management. Clin Gastroenterol Hepatol (2015) 0.79
(1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy. World J Hepatol (2015) 0.79
Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther (2012) 0.77
Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort. Hepat Res Treat (2013) 0.76
Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C. J Neurovirol (2013) 0.76
Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy. Gastroenterol Res Pract (2016) 0.75
Colectomy for Porto-Systemic Encephalopathy: Is it Still Topical? Clin Pract (2013) 0.75
Hepatic encephalopathy and mild lack of awareness. Aliment Pharmacol Ther (2010) 0.75
Covert Hepatic Encephalopathy: Can My Patient Drive? J Clin Gastroenterol (2016) 0.75
Advances in cirrhosis: Optimizing the management of hepatic encephalopathy. World J Hepatol (2015) 0.75
Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial. Middle East J Dig Dis (2017) 0.75
Hepatic Encephalopathy: From the Pathogenesis to the New Treatments. ISRN Hepatol (2014) 0.75
Management of hepatic encephalopathy by traditional chinese medicine. Evid Based Complement Alternat Med (2012) 0.75
Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis. World J Hepatol (2016) 0.75
Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy. Patient Prefer Adherence (2014) 0.75
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions. Gut Liver (2016) 0.75
Limonene in exhaled breath is elevated in hepatic encephalopathy. J Breath Res (2016) 0.75
Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment Pharmacol Ther (2010) 1.05